CRDC: Buy Rating, $18 Price Target

‘The announcement is ``one of the most important game- changing events in the cardiovascular landscape,\'\' wrote Merriman\'s Jose Haresco. He has a buy rating on Cardica shares and expects them to reach $18.’

http://www.bloomberg.com/apps/news?pid=c...